Streetbeat News

Stock Prices

SYTA

Trading halt status for SYTA was updated at 8:55:00 AM ET. The halt was due to pending news and the resumption times were provided.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 12:55 pm

FND

Floor & Decor Holdings shares are trading lower after the company reported mixed Q2 financial results and cut its FY24 guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 12:54 pm

OMI

Owens & Minor Inc. (NYSE:OMI) reported Q2 2024 results with adjusted EPS of $0.36, beating the consensus of $0.33. Sales were $2.671 billion, up 4% year-over-year. The company reaffirmed its 2024 revenue guidance of $10.5 billion-$10.9 billion and adjusted EPS guidance of $1.40-$1.70. Despite the positive results, OMI stock was trading lower by 3.90% premarket.

Portfolio Pulse from Vandana Singh

August 02, 2024 | 12:54 pm

SNAP

Snap Inc. (NYSE:SNAP) reported weaker-than-expected Q2 revenue, leading to a 3.8% drop in share price. Analysts from JP Morgan and Susquehanna cut their price targets for Snap.

Portfolio Pulse from Avi Kapoor

August 02, 2024 | 12:53 pm

SNDL

SNDL Inc. reported a 1.6% YoY drop in Q2 revenue due to softness in the liquor segment, while cannabis operations showed strong growth. The company achieved a record gross margin of 25.5% and significantly reduced its net loss. SNDL also announced a restructuring project expected to save over CA$20 million annually.

Portfolio Pulse from Nina Zdinjak

August 02, 2024 | 12:51 pm

NU

Nu Holdings shares are trading lower after UBS downgraded the stock from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 12:50 pm

AAPL

AMZN

META

MSFT

SPY

A Benzinga poll reveals that over 70% of investors believe the stock market has not yet peaked in 2024, with expectations of new highs by year-end. The SPDR S&P 500 ETF Trust (SPY) is up 18.4% year-to-date. Earnings reports from Apple (AAPL), Amazon (AMZN), Meta Platforms (META), and Microsoft (MSFT) showed mixed results, with Amazon missing net sales estimates but beating EPS expectations. Historical trends suggest a challenging August and September for the S&P 500.

Portfolio Pulse from Chris Katje

August 02, 2024 | 12:47 pm

ADAP

GLPG

The FDA has approved Adaptimmune Therapeutics' (NASDAQ:ADAP) Tecelra for treating unresectable or metastatic synovial sarcoma, marking the first engineered cell therapy for solid tumors in the U.S. and the first new therapy for this rare cancer in over a decade. The approval is based on the SPEARHEAD-1 trial results, showing a 43% overall response rate. Adaptimmune plans to establish multiple treatment centers. Additionally, Adaptimmune has entered a collaboration with Galapagos NV (NASDAQ:GLPG) for future TCR T-cell therapies.

Portfolio Pulse from Vandana Singh

August 02, 2024 | 12:46 pm

MCHP

Microchip Technology (NASDAQ:MCHP) reported mixed Q1 results, beating earnings estimates but missing revenue expectations. The company provided a cautious Q2 outlook, leading to a 5% drop in share price. Analysts from B of A Securities, Susquehanna, and JP Morgan lowered their price targets.

Portfolio Pulse from Avi Kapoor

August 02, 2024 | 12:46 pm

NXT

Nextracker shares are trading lower following the company's Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 02, 2024 | 12:44 pm